FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 60 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $659,000 | -56.1% | 277,096 | -30.8% | 0.00% | – |
| Q1 2019 | $1,502,000 | -9.7% | 400,534 | -13.6% | 0.00% | -100.0% |
| Q4 2018 | $1,664,000 | -54.3% | 463,511 | -27.1% | 0.00% | 0.0% |
| Q3 2018 | $3,645,000 | +45.1% | 636,127 | +26.9% | 0.00% | 0.0% |
| Q2 2018 | $2,512,000 | -2.4% | 501,451 | -0.1% | 0.00% | 0.0% |
| Q1 2018 | $2,575,000 | -20.0% | 501,831 | -6.4% | 0.00% | 0.0% |
| Q4 2017 | $3,220,000 | +1.5% | 535,914 | -6.2% | 0.00% | 0.0% |
| Q3 2017 | $3,172,000 | +25.5% | 571,639 | +4.9% | 0.00% | 0.0% |
| Q2 2017 | $2,528,000 | +30.0% | 544,853 | +38.6% | 0.00% | 0.0% |
| Q1 2017 | $1,945,000 | -66.3% | 393,004 | -24.5% | 0.00% | -50.0% |
| Q4 2016 | $5,777,000 | +18.9% | 520,486 | -0.8% | 0.00% | +100.0% |
| Q3 2016 | $4,857,000 | +38.7% | 524,474 | -4.9% | 0.00% | 0.0% |
| Q2 2016 | $3,501,000 | -13.2% | 551,350 | -10.9% | 0.00% | 0.0% |
| Q1 2016 | $4,033,000 | -23.6% | 618,580 | -4.9% | 0.00% | -50.0% |
| Q4 2015 | $5,277,000 | -6.6% | 650,731 | -15.6% | 0.00% | 0.0% |
| Q3 2015 | $5,648,000 | -16.0% | 770,559 | +17.5% | 0.00% | 0.0% |
| Q2 2015 | $6,722,000 | – | 655,879 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,293,177 | $4,643,000 | 4.08% |
| GREAT POINT PARTNERS LLC | 4,047,561 | $14,531,000 | 1.84% |
| Sio Capital Management, LLC | 1,151,510 | $4,134,000 | 1.51% |
| DAFNA Capital Management LLC | 808,000 | $2,901,000 | 1.44% |
| Diag Capital Management, LP | 146,432 | $960,000 | 1.10% |
| Perceptive Advisors | 4,661,824 | $15,850,000 | 0.60% |
| Eversept Partners, LP | 294,660 | $1,057,829 | 0.57% |
| Sofinnova Investments, Inc. | 832,293 | $2,987,000 | 0.37% |
| KNOTT DAVID M | 206,200 | $740,000 | 0.35% |
| Orbimed Advisors | 5,195,330 | $18,651,000 | 0.34% |